President Trump issued an executive order aiming to lower prescription drug prices in the US to match those in other developed countries. He claimed an almost immediate 30-80% reduction. However, experts say the order's implementation, involving a 30-day target setting period followed by a potential lengthy rulemaking process, will not yield immediate results. The order's success depends on drug companies' cooperation and may require Congressional action, potentially facing legal challenges and political opposition. While price reductions are possible, the timeframe is far from 'immediate'.

Prepared by Anthony Ross and reviewed by editorial team.